Barclays Cuts Stem (NYSE:STEM) Price Target to $8.00

Stem (NYSE:STEM) had its price objective trimmed by Barclays from $18.00 to $8.00 in a research note released on Monday, Marketbeat reports. The firm currently has an equal weight rating on the stock.

Several other research analysts have also issued reports on the company. Weiss Ratings lowered Stem from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, April 29th. UBS Group reissued a “neutral” rating and set a $10.50 price objective (down from $12.00) on shares of Stem in a research note on Monday, May 11th. Susquehanna reduced their price target on shares of Stem from $10.00 to $7.50 and set a “neutral” rating on the stock in a research report on Friday, July 10th. Wall Street Zen downgraded Stem from a “sell” rating to a “strong sell” rating in a research note on Saturday, May 9th. Finally, Roth Capital reaffirmed a “neutral” rating and set a $11.00 price target on shares of Stem in a research report on Thursday, May 7th. Four research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $9.00.

Stem Price Performance

Shares of Stem stock opened at $4.94 on Monday. The firm has a 50 day simple moving average of $7.65 and a 200 day simple moving average of $10.42. Stem has a fifty-two week low of $4.92 and a fifty-two week high of $32.23. The firm has a market cap of $44.26 million, a P/E ratio of -0.57 and a beta of 1.45.

Stem (NYSE:STEM) last released its earnings results on Wednesday, May 6th. The company reported ($2.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.76) by ($0.46). The firm had revenue of $29.00 million during the quarter, compared to the consensus estimate of $34.61 million. On average, sell-side analysts expect that Stem will post -7.76 EPS for the current year.

Institutional Investors Weigh In On Stem

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. AQR Capital Management LLC increased its position in shares of Stem by 505.8% in the first quarter. AQR Capital Management LLC now owns 1,482,790 shares of the company’s stock valued at $519,000 after acquiring an additional 1,238,012 shares during the last quarter. Vanguard Group Inc. increased its holdings in Stem by 2.2% during the third quarter. Vanguard Group Inc. now owns 395,223 shares of the company’s stock worth $6,924,000 after buying an additional 8,468 shares during the last quarter. Bank of America Corp DE lifted its stake in Stem by 104.0% in the third quarter. Bank of America Corp DE now owns 217,871 shares of the company’s stock valued at $3,817,000 after acquiring an additional 111,068 shares during the last quarter. Two Sigma Investments LP increased its stake in shares of Stem by 461.9% during the 3rd quarter. Two Sigma Investments LP now owns 94,045 shares of the company’s stock worth $1,648,000 after purchasing an additional 77,307 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of Stem by 2.1% in the 4th quarter. Geode Capital Management LLC now owns 88,246 shares of the company’s stock valued at $1,329,000 after purchasing an additional 1,821 shares during the period. 61.63% of the stock is owned by institutional investors.

More Stem News

Here are the key news stories impacting Stem this week:

• Neutral Sentiment: Several headlines about STEM education conferences, teachers, student programs, research and stem-cell donors relate to education or healthcare—not Stem, Inc.—and are unlikely to affect the company’s shares.
• Negative Sentiment: Barclays issued a pessimistic forecast for Stem, Inc. (NYSE: STEM), potentially reinforcing investor concerns about the company’s outlook and valuation. Barclays Issues Pessimistic Forecast for Stem Stock Price
• Negative Sentiment: Chief Financial Officer Brian Musfeldt sold 996 shares for approximately $6,086 at an average price of $6.11. The transaction reduced his direct ownership by 29.51%, a potentially negative signal because insider selling can raise concerns about management’s confidence, although the dollar amount was relatively small. Stem CFO SEC Insider Trading Filing
• Negative Sentiment: Stem’s latest reported quarter showed a loss of $2.22 per share, worse than the expected $1.76 loss, while revenue of $29.0 million missed the $34.61 million consensus estimate. Analysts expect a full-year loss of $7.76 per share, highlighting continuing profitability concerns.

About Stem

Stem, Inc is a technology company specializing in AI-driven energy storage and optimization solutions for commercial, industrial and utility customers. The company delivers integrated hardware and software systems that enable clients to manage energy consumption, reduce peak demand charges and provide ancillary services to the power grid. By combining battery storage hardware with advanced machine-learning algorithms, Stem helps organizations align energy usage with cost-saving opportunities while supporting grid reliability and renewable integration.

At the core of Stem’s offering is its Athena software platform, which uses real-time data and predictive analytics to forecast energy needs and automatically dispatch stored energy when it is most valuable.